Avantor/$AVTR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Avantor

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Ticker

$AVTR
Sector

Primary listing

NYSE

Employees

13,500

Avantor Metrics

BasicAdvanced
$8.4B
12.19
$1.01
1.05
-

What the Analysts think about Avantor

Analyst ratings (Buy, Hold, Sell) for Avantor stock.

Bulls say / Bears say

Avantor has expanded its cost transformation program, now targeting $400 million in gross run-rate savings by end-2027 to drive margin expansion and offset revenue pressures (PR Newswire)
Second‐quarter free cash flow of $125.4 million and operating cash flow of $154.4 million demonstrate strong cash generation capacity to fund operations and deleveraging efforts (PR Newswire)
Activist investor Engine Capital’s public call for a board overhaul and suggestion that a sale could fetch $17–$19 per share highlights potential value‐unlocking catalysts and an underappreciated stock valuation (Reuters)
CEO Michael Stubblefield’s announced resignation and ongoing leadership search have introduced executive uncertainty that may weigh on strategic execution and investor confidence (PR Newswire)
Laboratory Solutions segment continues to face demand headwinds, with Q1 organic net sales declining 2% year-over-year and Q2 organic sales flat, underscoring persistent weakness in education and government end markets (PR Newswire)
Adjusted net leverage remains elevated at 3.2x EBITDA as of June 30, 2025, constraining financial flexibility and potentially increasing interest expense headwinds (PR Newswire)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.

Avantor Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Avantor Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AVTR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs
Buy Avantor stock | $AVTR Share Price | Lightyear